Comparative Study
Collateral sensitivity to methotrexate in cells resistant to adriamycin
- PMID: 445393
Item in Clipboard
Comparative Study
Collateral sensitivity to methotrexate in cells resistant to adriamycin
Cancer Res.
1979 Jun.
No abstract available
Similar articles
-
Enhancement of the frequency of methotrexate resistance by gamma-radiation in Chinese hamster ovary and mouse 3T6 cells.Cancer Res. 1989 Jul 15;49(14):3861-6. Cancer Res. 1989. PMID: 2736529
-
Reversal of resistance to methotrexate by hyperthermia in Chinese hamster ovary cells.Cancer Res. 1981 Oct;41(10):3840-3. Cancer Res. 1981. PMID: 7284991
-
Survival and cell kinetics effects of adriamycin on mammalian cells.Cancer Res. 1973 Jan;33(1):11-6. Cancer Res. 1973. PMID: 4734161 No abstract available.
-
Cellular and molecular effects of adriamycin on dividing and nondividing cells.Pharmacol Ther. 1984;24(3):303-19. doi: 10.1016/0163-7258(84)90007-x. Pharmacol Ther. 1984. PMID: 6379686 Review. No abstract available.
-
Third Myron Karon Memorial Lecture. Resistance of human tumors to cancer chemotherapeutic agents: an important research problem.Med Pediatr Oncol. 1978;5(1):105-14. doi: 10.1002/mpo.2950050117. Med Pediatr Oncol. 1978. PMID: 370531 Review.
Cited by
-
Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Chem Rev. 2014 Jun 11;114(11):5753-74. doi: 10.1021/cr4006236. Epub 2014 Apr 23. Chem Rev. 2014. PMID: 24758331 Free PMC article. Review. No abstract available.
-
The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.J Neurooncol. 1987;5(3):195-203. doi: 10.1007/BF00151222. J Neurooncol. 1987. PMID: 3479534
-
Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.Cancer Chemother Pharmacol. 1985;15(1):31-4. doi: 10.1007/BF00257290. Cancer Chemother Pharmacol. 1985. PMID: 4006047
-
Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?Drug Metab Dispos. 2014 Apr;42(4):623-31. doi: 10.1124/dmd.113.056176. Epub 2014 Feb 3. Drug Metab Dispos. 2014. PMID: 24492893 Free PMC article. Review.
-
Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].Cancer Chemother Pharmacol. 1982;8(1):73-5. doi: 10.1007/BF00292874. Cancer Chemother Pharmacol. 1982. PMID: 6954016
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources